Mogrify

Cambridge, United Kingdom

MogrifyAE will transform the lives of patients with degenerative diseases through a novel class of in vivo reprogramming therapies.

$10.0M raised

Oct 2023

Series A

Top Investors

Ahren Innovation CapitalParkwalk Advisors24 HaymarketAstellas Venture ManagementAerion Partners

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Mogrify raised?

Mogrify has raised $10.0M in total funding. The most recent round was Series A. The last funding was announced in October 2023.

Who are Mogrify's investors?

Mogrify's investors include Ahren Innovation Capital, Parkwalk Advisors, 24 Haymarket, Astellas Venture Management, Aerion Partners.

Where is Mogrify headquartered?

Mogrify is headquartered in Cambridge, United Kingdom.

What does Mogrify do?

MogrifyAE will transform the lives of patients with degenerative diseases through a novel class of in vivo reprogramming therapies.

What stage is Mogrify at?

Mogrify is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 2, 2023.

MLA

"Mogrify — Funding & Investors." VCBacked, October 2, 2023, https://www.vcbacked.co/company/mogrify. Accessed June 5, 2026.

APA

VCBacked. (2023). Mogrify — Funding & Investors. Retrieved June 5, 2026, from https://www.vcbacked.co/company/mogrify

Wikipedia (cite web)

{{cite web |title=Mogrify — Funding & Investors |url=https://www.vcbacked.co/company/mogrify |website=VCBacked |access-date=June 5, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 2, 2023.